SAMUEL BRANDON: Open Payments
NPI 1992554448 · DECATUR, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 15 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $218 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $182 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $176 |
| AstraZeneca Pharmaceuticals LP | 2 | $153 |
| Corcept Therapeutics | 1 | $20 |
Products named: CAPLYTA, Wegovy, AIRSUPRA, BREZTRI, Rybelsus, Korlym, Ozempic.
Industry payments across AL — which companies pay providers there.
